Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Treatment for shoulder pain after stroke

Official title: Quantifying and Treating Myofascial Dysfunction in Post Stroke Shoulder Pain

Run by Johns Hopkins University · NCT06718413 · Data updated 2026-11-12

This study is testing whether hyaluronidase injections can help reduce shoulder pain in stroke survivors and improve their movement and quality of life.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment68 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedMarch 28, 2025
Main results expectedAugust 31, 2027
Study endsAugust 31, 2028
Registry record updatedOctober 14, 2026
Trial IDNCT06718413 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have experienced hemiparesis from a stroke and exhibit specific shoulder mobility issues.

Probably not a fit

Patients with other neurological conditions or significant cognitive dysfunction may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to investigate the effectiveness of hyaluronidase injections in reducing shoulder pain associated with post-stroke myofascial dysfunction. It will utilize T1rho MRI and ultrasound shear strain mapping to quantify changes in muscle function and pain levels before and after treatment. The study will compare the outcomes of patients receiving hyaluronidase versus a placebo, focusing on pain reduction, range of motion, and overall quality of life. The trial seeks to clarify the role of hyaluronic acid accumulation in shoulder pain post-stroke.

Why it matters

Potential benefit: If successful, this treatment could significantly alleviate shoulder pain and improve recovery outcomes for stroke patients.

How similar studies have gone: While the approach of using hyaluronidase for myofascial dysfunction is novel, similar studies have shown promise in treating pain through targeted interventions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age ≥18 years;
* hemiparesis from an ischemic or hemorrhagic stroke;
* time since cerebral injury 3-180 months prior;
* show a difference of more than 10 degrees of passive ER-ROM between non-paretic and paretic shoulders with or without pain
* ability to give informed consent and HIPAA authorization, and comply with study protocols;

Exclusion Criteria:

* treatment of spasticity with Botulinum toxin or intrathecal baclofen within the past three months, phenol injections within the past 12 months, or ongoing adjustment of anti-spastic medications;
* other neurologic condition that may affect motor response (e.g., Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), MS);
* clinically significant cognitive dysfunction with score \<19 on Folstein's Mini Mental Status Examination or positive depression screening on the Patient Health Questionnaire (PHQ)-9;
* pregnancy;
* known hypersensitivity to hyaluronidase;
* standard contraindications for MRI;
* have non-musculoskeletal PSSP such as only central pain or chronic regional pain syndrome (CRPS)
* any condition that will preclude the patient from completing the protocol as determined by the PI.

Where it's running

  • Johns Hopkins University
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Ning Cao, MD — Johns Hopkins University
  • Study coordinator: Ning Cao, MD
  • Email: ncao2@jhmi.edu
  • Phone: 718-801-0026

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.